Toxic neurofilamentous axonopathies accumulation of neurofilaments and axonal degeneration

dc.contributor.authorLlorens i Baucells, Jordi
dc.date.accessioned2013-11-11T08:37:04Z
dc.date.available2013-11-11T08:37:04Z
dc.date.issued2013-05
dc.date.updated2013-11-11T08:37:05Z
dc.description.abstractA number of neurotoxic chemicals induce accumulation of neurofilaments in axonal swellings that appear at varying distances from the cell body. This pathology is associated with axonal degeneration of different degrees. The clinical manifestation is most commonly that of a mixed motor-sensory peripheral axonopathy with a disto-proximal pattern of progression, as in cases of chronic exposure to n-hexane and carbon disulphide. It has been demonstrated that protein adduct formation is a primary molecular mechanism of toxicity in these axonopathies, but how this mechanism leads to neurofilament accumulation and axonal degeneration remains unclear. Furthermore, little is known regarding the mechanisms of neurofilamentous axonopathy caused by 3,3′-iminodipropionitrile, an experimental toxin that induces proximal axon swelling that is strikingly similar to that found in early amyotrophic lateral sclerosis. Here, we review the available data and main hypotheses regarding the toxic axonopathies and compare them with the current knowledge of the biological basis of neurofilament transport. We also review recent studies addressing the question of how these axonopathies may cause axonal degeneration. Understanding the mechanisms underlying the toxic axonopathies may provide insight into the relationship between neurofilament behaviour and axonal degeneration, hopefully enabling the identification of new targets for therapeutic intervention. Because neurofilament abnormalities are a common feature of many neurodegenerative diseases, advances in this area may have a wider impact beyond toxicological significance
dc.format.extent12 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec617656
dc.identifier.issn0954-6820
dc.identifier.pmid23331301
dc.identifier.urihttps://hdl.handle.net/2445/47644
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofVersió preprint del document publicat a: http://dx.doi.org/10.1111/joim.12030
dc.relation.ispartofJournal of Internal Medicine, 2013, vol. 273, num. 5, p. 478-489
dc.relation.urihttp://dx.doi.org/10.1111/joim.12030
dc.rights(c) The Association for the Publication of the Journal of Internal Medicine, 2013
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationNeurotoxines
dc.subject.classificationNitrils
dc.subject.classificationEsclerosi lateral amiotròfica
dc.subject.otherNeurotoxins
dc.subject.otherNitriles
dc.subject.otherAmyotrophic lateral sclerosis
dc.titleToxic neurofilamentous axonopathies accumulation of neurofilaments and axonal degeneration
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/submittedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
617656.pdf
Mida:
129.44 KB
Format:
Adobe Portable Document Format